David L Ball
Overview
Explore the profile of David L Ball including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
951
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Siva S, Jones G, Bressel M, Shaw M, Chander S, Chu J, et al.
Int J Radiat Oncol Biol Phys
. 2022 Jun;
114(5):862-870.
PMID: 35752407
Purpose: Medical operability is prognostic for survival after SABR in primary malignancies. This study investigated the prognostic significance of medical operability and total versus subtotal ablation of all oligometastatic disease...
2.
Hanna G, John T, Ball D
Transl Lung Cancer Res
. 2021 May;
10(4):2079-2087.
PMID: 34012816
Malignant pleural mesothelioma is an uncommon thoracic cancer with a relatively poor outcome, which has only seen modest improvements when compared to non-small cell lung cancer. The mainstays of treatment...
3.
Lobachevsky P, Bucknell N, Mason J, Russo D, Yin X, Selbie L, et al.
Cancers (Basel)
. 2020 Sep;
12(9).
PMID: 32899789
Thoracic radiotherapy (RT) is required for the curative management of inoperable lung cancer, however, treatment delivery is limited by normal tissue toxicity. Prior studies suggest that using radiation-induced DNA damage...
4.
Alexander M, Solomon B, Ball D, Sheerin M, Dankwa-Mullan I, Preininger A, et al.
JAMIA Open
. 2020 Aug;
3(2):209-215.
PMID: 32734161
Objective: The objective of this technical study was to evaluate the performance of an artificial intelligence (AI)-based system for clinical trials matching for a cohort of lung cancer patients in...
5.
Sogono P, Ball D, Siva S
Ann Transl Med
. 2020 Jan;
7(22):615.
PMID: 31930016
No abstract available.
6.
Iravani A, Turgeon G, Akhurst T, Callahan J, Bressel M, Everitt S, et al.
Eur J Nucl Med Mol Imaging
. 2019 Jun;
46(9):1869-1877.
PMID: 31190177
Purpose: Inflammatory FDG uptake in the lung (PET-pneumonitis) following curative-intent radiotherapy (RT)/chemo-RT (CRT) in non-small cell lung cancer (NSCLC) can pose a challenge in FDG-PET/CT response assessment. The aim of...
7.
Siva S, Ball D
Int J Radiat Oncol Biol Phys
. 2019 Mar;
103(5):1085-1087.
PMID: 30900559
No abstract available.
8.
Yin X, Mason J, Lobachevsky P, Munforte L, Selbie L, Ball D, et al.
Int J Radiat Oncol Biol Phys
. 2018 Oct;
103(2):521-531.
PMID: 30312716
Purpose: There is growing interest in developing individually tailored cancer radiation therapy (RT), wherein patients with high intrinsic radiosensitivity are identified before commencing treatment, to minimize severe adverse reactions. In...
9.
Turgeon G, Iravani A, Akhurst T, Beaulieu A, Callahan J, Bressel M, et al.
J Nucl Med
. 2018 Jul;
60(3):328-334.
PMID: 30030343
The optimal methodology for defining response with F-FDG PET after curative-intent chemoradiation for non-small cell lung cancer (NSCLC) is unknown. We compared survival outcomes according to the criteria of the...
10.
Alexander M, Evans S, Wolfe R, Ball D, Burbury K
Med J Aust
. 2017 Aug;
207(3):126.
PMID: 28764629
No abstract available.